Hong Kong Exchange CEO to Step Down Earlier Than Planned
By Tracy Qu
Hong Kong Exchanges & Clearing Chief Executive Nicolas Aguzin will step down at the end of February, three months earlier than expected, as the international financier seeks to accelerate the leadership transition.
In a statement on Friday, Hong Kong's stock-exchange operator said Aguzin "believes it would be in the interest of HKEX to accelerate the change in leadership." Aguzin's term was to end in May after he said in December that he wouldn't seek reappointment.
The board has appointed Bonnie Yiting Chan, HKEX's co-chief operating officer, as the new CEO. She will serve a three-year term from March 1.
Aguzin, who was an executive at JPMorgan Chase, joined in 2021 and is credited with steering the stock exchange through a difficult period.
"During his tenure as chief executive, and against a challenging macro backdrop shaped by Covid and weak global markets, Aguzin has strengthened HKEX's core competencies and enhanced HKEX's international presence," the statement said.
Chan's appointment comes as Hong Kong's position as a top IPO destination is in question, with investors pessimistic about China's slowing economy and the deepening rout in the Chinese equity market. According to the exchange, the HKEX had 64 new listings in 2023, raising HK$40.9 billion as of Dec. 15. Last year, the Hang Seng Index fell 14%, its fourth consecutive annual loss.
Hong Kong's benchmark stock index has declined 7.6% so far this year, making it one of the worst performers in Asia.
Write to Tracy Qu at tracy.qu@wsj.com
(END) Dow Jones Newswires
February 09, 2024 02:51 ET (07:51 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth